Cantitate/Preț
Produs
Total produse
Vezi coșul
EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person de Bill Brennan

EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person

Autor Bill Brennan, Alex Belser
en Limba Engleză Paperback – 29 aug 2024

Observăm în peisajul medical actual o tranziție rapidă a substanțelor psihedelice de la statutul de curiozitate experimentală la cel de instrumente terapeutice riguros reglementate. EMBARK Psychedelic Therapy for Depression, publicat de Oxford University Press, nu este doar un manual tehnic, ci un cadru de lucru complet, conceput pentru a umaniza și a structura administrarea acestor medicamente în tratamentul depresiei rezistente. Ne-a atras atenția în mod deosebit rigoarea cu care autorii, Bill Brennan și Alex Belser, propun modelul EMBARK ca răspuns la lacunele modelelor anterioare, punând un accent deosebit pe etică și pe dimensiunea corporală a experienței.

Din punct de vedere clinic, lucrarea se distinge prin structura sa bazată pe șase domenii esențiale: de la sfera existențial-spirituală la cea afectiv-cognitivă, oferind terapeuților un limbaj comun pentru a naviga stările modificate de conștiință. Acolo unde The Psychedelic Therapy Workbook de Elizabeth Nielson oferă un ghid practic centrat pe pacient pentru diverse afecțiuni, acest volum aprofundează mecanismele psihologice de schimbare specifice depresiei, oferind agende de lucru și protocoale de integrare bazate pe dovezi solide. Merită menționat că modelul a demonstrat o eficacitate remarcabilă în studiile clinice, cu o persistență a remisiunii de 75% la patru luni după intervenție.

Abordarea este una „trans-drug”, ceea ce înseamnă că principiile pot fi aplicate indiferent de molecula utilizată, fie că vorbim de protocoale cu psilocibină sau asistate de ketamină. Tonul este clinic și precis, orientat spre siguranța pacientului și competența culturală a practicianului, transformând o experiență adesea subiectivă într-un proces terapeutic replicabil și etic.

Citește tot Restrânge

Preț: 18338 lei

Preț vechi: 26148 lei
-30%

Puncte Express: 275

Carte disponibilă

Livrare economică 08-19 mai
Livrare express 24-30 aprilie pentru 9520 lei

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă

Specificații

ISBN-13: 9780197762592
ISBN-10: 019776259X
Pagini: 328
Ilustrații: 14 b/w illustrations
Dimensiuni: 155 x 236 x 25 mm
Greutate: 0.48 kg
Editura: Oxford University Press
Colecția OUP USA
Locul publicării:New York, United States

De ce să citești această carte

Această carte este esențială pentru psihiatri și psihologi clinici care doresc să integreze terapiile asistate de psihedelice în practica lor. Cititorul câștigă acces la modelul EMBARK, un cadru teoretic și practic open-source, validat clinic, care pune accent pe siguranța etică și pe integrarea holistică a experienței. Este resursa definitivă pentru a înțelege cum pot fi utilizate noile frontiere ale farmacologiei pentru a obține remisiunea pe termen lung în depresie.

Despre autor

Bill Brennan și Alex Belser sunt figuri centrale în cercetarea contemporană asupra psihedelicelor. Dr. Alex Belser este psiholog clinician și cercetător asociat la Universitatea Yale, fiind implicat în studii de pionierat privind psilocibina și MDMA. Bill Brennan aduce o expertiză vastă în dezvoltarea modelelor de formare pentru terapeuți, fiind co-creatorul modelului EMBARK. Împreună, aceștia au instruit mii de profesioniști din domeniul sănătății mintale, militând pentru o abordare a terapiei psihedelice care să fie accesibilă, etică și fundamentată științific.

Descriere

EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person represents a critical step forward in the field of psychedelic therapy. The book is a comprehensive guide for clinicians, offering a groundbreaking therapeutic framework for administering psychedelic medicines in treating depression.The approach is gaining traction with 4,000 people registered for the EMBARK foundational training. Developed in response to identified gaps in existing models of psychedelic therapy, the EMBARK model addresses the need for an ethical and inclusive approach. It bridges gaps from previous psychedelic therapies, such as lack of attentiveness to the body and rigorous ethical practice. The EMBARK approach has a growing evidence-base: in a recent psychedelic clinical trial, 79% of participants schieved full remission from depression three weeks after treatment. Benefit persisted with 75% of participants in remission at the four-month follow upEMBARK offers a transdiagnostic and trans-drug approach adaptable to various indications and psychedelic medicines. It's built on four Cornerstones of Care: Trauma-Informed Care, Culturally Competent Care, Ethically Rigorous Care, and Collective Care, reflecting the belief that efficacious treatment is ethical treatment. The EMBARK acronym represents six Clinical Domains that commonly emerge for people in psychedelic experiences: Existential-Spiritual, Mindfulness, Body Aware, Affective-Cognitive, Relational, and Keeping Momentum.The book provides practical instructions and suggested agendas for therapists, and offers a flexible, participant-centric approach to integration, focusing on the clinical domains that emerged for the participant. It also links theory to practice for the treatment of depression, drawing from twelve proposed psychological mechanisms of therapeutic change in psychedelic therapy, and provides a comprehensive guide to treatment factors. EMBARK psychedelic therapy is open-sourced to the clinical community for development and adaptation to other psychedelic medicines, diverse populations, and to inform the development of psychedelic practitioner trainings, making it an essential resource for those interested in the field of psychedelic therapy.

Recenzii

This book marks an exciting milestone in psychedelic-assisted therapy. Not only is it a really comprehensive guide to what to actually 'do,' the authors offer their wisdom from their whole selves, bringing a level of sensitivity and depth that befits these sacred ways of healing.
There are few people I admire more in this field than Alex Belser. He commits to a meticulous inquiry, infused with integrity. He and Bill Brennan have written a much-needed practical, thoughtful guide to treating the whole being (physical, psychological, spiritual and otherwise) of a depressed person with psychedelic-assisted psychotherapy.
This comprehensive book reminds us of the depth, range, and complexity of psychedelic experiences, and gives therapists a framework for engaging with the full potential of psychedelic-assisted therapy. It comes at a critical time if we are to remain open to transforming the way we support each other in healing.
Well-trained therapists are the key to generating successful outcomes from psychedelic-assisted therapy, the psychedelics themselves are just tools that need to be used wisely and compassionately. Pioneering, comprehensive, and deeply insightful-EMBARK points the way to the future of psychedelic-assisted therapy. Brennan and Belser's commitment to holistic and ethical care is a profoundly valuable guide to practitioners and patients.
Brennan and Belser's remarkable manual offers an approach both visionary and practical. Their method recognizes the psychological, social, and spiritual aspects that are central to the psychedelic healing of depression, allowing the reader to discover the unique location for that therapist, that patient, and the medicine that connects them.
This book is not only the newest but focused specifically on therapists and the therapist's role in helping clients who are receiving psychedelic-assisted therapy for the treatment of depression.

Notă biografică

Bill Brennan, PhD, is a psychologist in New York City who has served as a clinical advisor at Cybin, Inc. and Gilgamesh Pharmaceuticals. He is a co-creator of the EMBARK approach to psychedelic therapy and is a core faculty member in the EMBARK psychedelic facilitator training program. He has trained and supervised psychedelic facilitators in several studies and has been the lead author of several psychedelic treatment manuals. He currently serves as an advisory board member of New Yorkers for Mental Health Alternatives.Alex Belser, PhD, is a clinical scientist, psychologist, author, and leader in psychedelic research. As a Co-Investigator at Yale University, he is exploring psilocybin therapy to treat OCD. With a strong commitment to developing psychedelic therapies, he has conducted clinical trials investigating the potential of psilocybin, MDMA, ketamine, and DMT in addressing depression, anxiety, addiction, and PTSD. He co-founded the non-profit Nautilus Sanctuary and the New YorkUniversity Psychedelic Research Group in 2006. He served as the Chief Clinical Officer at Cybin and Adelia Therapeutics. He is the co-editor of Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine (2022).